Check My Meds

Fake medicines are a growing healthcare problem that have been around since the earliest days of medicine, yet have greatly increased in their prevalence and sophistication during the past few decades. Whether patients buy medicines online or offline, they should be able to trust that the medicines they are taking are authentic. The good news: in December 2014 EMD Serono, a pharmaceutical manufacturer specializing in HIV-associated Wasting, infertility and relapsing Multiple Sclerosis therapeutics, released Check My Meds™,  Read more…

Trick or Treat (ment)?

What drives comsumers in the EU into buying medicines online? How are EU countries winning and losing in the fight against fake medicines? Does the public know of the new European Commission logo that certifies online medicines sellers as safe and genuine? “Trick or Treat(ment)”  is a set of guidelines for safe online purchases of medicinal products in the EU, presented at Fakecare/Fakeshare conferences this spring in Rome.  These meetings see leading experts across industries sharing Read more…

Mobile Verification of Medicines comes to Saudi Arabia

Our partner Sproxil has established a partnership with Mobile Health Management Company (mHealth) to bring Sproxil’s Mobile Product Authentication (MPA) technology to the Saudi Arabia. MPA is offered free of cost to help consumers differentiate between fake and genuine medicines with a single text message. See how MPA works here. This new agreement offers a timely step forward following growing concerns over the influx of fake medicines in Gulf States. See the press report here.

Speaking up about fake medicines in Somalia

Following Al Jazeera feature by Hamza Mohamed|on the impact of fake medicines in Somalia, local communities are stepping up the fight against these dangerous products. Starting 07 July, Radio Dalsan, a community radio channel based in Mogadishu, Somalia, has begun live programming on fake medicines, sharing vital information to help the public stay safe. Fight the Fakes congratulates Radio Dalsan on its efforts and looks forward to updates! Visit their website here.       Except from Al Read more…

ASOP Global #BuySafeRx

Fight the Fakes partner the Alliance for Safe Online Pharmacy (ASOP) #BuySafeRx campaign shares with US-based consumers how to buy safe, genuine medicines online. Visit their website for information about the secure domain name “.pharmacy” and check out thier blog on USP’s Quality Matters: Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines

Indo-French Workshop on Combating Fake Medicines

On 23 and 24 June 2015, the 1st Indo-French workshop on combating fake medicines was held at the Central Bureau of Investigation (CBI) office in New Delhi. Jointly organized by our partner the Institute of Research Against Counterfeit Medicines (IRACM) and the internal security services of the Embassy of France in India, this operationally-oriented seminar was inaugurated by the Ambassador of France in India, François Richier, the Director of CBI, Anil Sinha, and the head of the Read more…

Le faux médicament, késako ?

A partir du 1er juillet 2015 et pour une durée de 6 mois, l’Institut de Recherche Anti-Contrefaçon de Médicaments (IRACM) lance une campagne de sensibilisation et d’information auprès du grand public et des patients français sur les risques liés à la consommation de médicaments contrefaits ou falsifiés. Cette campagne est déployée dans les salles d’attente des médecins généralistes à Paris et en Ile-de-France, et en région Provence-Alpes-Côte d’Azur, ainsi que dans les salles d’attentes des Read more…

Quality Matters: Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines

This article was originally published in Quality Matters. Global Health // June 30, 2015 Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines For nearly two centuries, USP has helped secure the quality of the American drug supply. USP’s drug standards are enforceable in the United States by the U.S. Food and Drug Administration (FDA), and these standards are used in more than 140 countries. Despite the efforts of USP and other pharmacopeias to Read more…

Subscribe to our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.